The novel Bach1 inhibitor HPP971 uniquely activates Nrf2 and reduces disease severity in a mouse model of experimental autoimmune encephalomyelitis | AVESİS

Istanbul Medipol University Research Information System

The novel Bach1 inhibitor HPP971 uniquely activates Nrf2 and reduces disease severity in a mouse model of experimental autoimmune encephalomyelitis

Copy For Citation

2014 Joint ACTRIMS-ECTRIMS Meeting, BOSTON, United States Of America, 9 September - 09 October 2014

Publication Type: Conference Paper
City: BOSTON
Country: United States Of America
Istanbul Medipol University Affiliated: Yes